Markets:

Overview

News

Currencies

International

Treasuries

Clearmind Medicine Inc. - Common Shares (NQ:CMND)

1.850 +0.200 (+12.12%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Clearmind Medicine Inc. - Common Shares

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More ↗

December 05, 2023

Defense Dept. Funds Ketamine Study For PTSD Treatment

Via Benzinga

Clearmind Medicine Achieved Positive Results in Cocaine Addiction Treatment

December 05, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical Trial

December 01, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

November 30, 2023

Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.

Via Benzinga

Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗

November 30, 2023

Shares of Salesforce, Inc.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

November 30, 2023

It's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 29, 2023

Pre-market stock movers are a good way to start the day as we dive into the biggest news worth checking out on Wednesday morning!

Via InvestorPlace

Why Clearmind Medicine Stock Is Moving Today ↗

November 28, 2023

Clearmind Medicine Inc. (NASDAQ: CMND) shares are trading higher on Tuesday after the company announced results from its weight loss and metabol

Via Benzinga

Clearmind Medicine Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic- Based Treatment

November 28, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

EXCLUSIVE: Clearmind Medicine's Psychedelic-Based Treatment Shows Encouraging Preclinical Activity In Obesity, Metabolic Disorders ↗

November 28, 2023

Clearmind Medicine Inc (NASDAQ: CMND) has released results from its pre-clinical trial of the combination therapy.

Via Benzinga

Clearmind Medicine to Participate in Traditional vs. Novel Psychedelics Virtual Event with Leading Industry Figures

November 27, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗

November 27, 2023

Shares of UP Fintech Holding Limited (NASDAQ: TIGR) surged in pre-market trading after the company results for the third quarter.

Via Benzinga

Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice ↗

November 21, 2023

Clearmind Medicine Inc. (NASDAQ: CMND) is set to conduct a 1-for-30 reverse share split of its issued and outstanding ordin

Via Benzinga

Clearmind Medicine Announces 1-for-30 Reverse Share Split

November 21, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Clearmind Medicine Announces Receipt of Nasdaq Delisting Notice and Plan for Immediate Recompliance

November 17, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Clearmind Medicine Announces Shareholders Meeting Results

November 15, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Clearmind Medicine to Pioneer Psychedelic Clinical Trials for Alcohol Use Disorder with Ivy League Universities

November 09, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 12, 2023

Gainers

Via Benzinga

Why BSQUARE Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket ↗

October 12, 2023

Gainers OpGen, Inc. (NASDAQ: OPGN) shares rose 432% to $1.79 in pre-market trading. Opgen said on Oct. 6, unit Curetis GMBH received payment of 750,000 euros related to the sale of certain Unyvero A50...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

October 12, 2023

Pre-market stock movers are a hot topic among traders on Thursday and we're offering all of the latest coverage this morning!

Via InvestorPlace

Clearmind Medicine to Present at the 8th Annual Dawson James Conference on October 12th

October 05, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 11, 2023

Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in...

Via Benzinga

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $2.25 Million Public Offering for Clearmind Medicine Inc. (NASDAQ:CMND)

September 19, 2023

Via ACCESSWIRE

Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise

September 20, 2023

EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:CMND),(NASDAQ:MNMD),(NYSE:CYBN),(NYSE:LLY) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death Intellectual Property

Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More ↗

September 18, 2023

Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next

Via Benzinga

Clearmind Medicine Closes US$2.25 Million Public Offering

September 18, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Psychedelics Capital Moves: Beckley Waves Raises $3.3M, Clearmind's $2.25M Public Offering ↗

September 15, 2023

Beckley Waves: $3.3 Million Round To Expand Safe & Legal Access To Psychedelic Therapies

Via Benzinga

Nasdaq Surges 100 Points; First Wave BioPharma Shares Spike Higher ↗

September 14, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.93% to 34,898.47 while the NASDAQ rose 0.75% to 13,917.44....

Via Benzinga

Topics Stocks

Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 14, 2023

Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 89.5% to $0.8243 after the company announced license agreement for capeserod from Sanofi.

Via Benzinga

Crude Oil Rises Sharply; BIOLASE Shares Plunge ↗

September 14, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.61% to 34,784.94 while the NASDAQ rose 0.71% to 13,911.78. The S&P...

Via Benzinga

Topics Stocks

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.